Inside Human Genome's
Earnings
[08/05/00]
Revenues
declined and net loss skyrocketed from a year ago,
but does this quarter's numbers really matter?RIMM: The Stock
that Can't Catch a Break
[07/01/00]
With a stock
price down 80% off its highs, investors are
wondering if their new spending plan is the way
to grow the company for the future.
BLyS Enters Clincal
Trials
[06/27/00]
Human Genome
Sciences has announced it will send its fourth
genomics-derived drug into clinical drug trials.
Find out what BlyS could mean to the future of
the company.
More Maria on HGSI
[06/03/00]
In part two of
our series, we take a look at the interview
between Maria Bartiromo and portfolio manager
Faraz Naqvi about Human Genome.
Maria Interviews
Human Genome
[05/31/00]
Maria
Bartiromo recently interviewed William Haseltine,
CEO of Human Genome Sciences, about the company
and its future in the biotech field.
|